Evaluation of endothelial dysfunction: flow-mediated dilation.

Area of Science:

• Vascular Biology
• Cardiovascular Medicine
• Diagnostic Methods

Background:

• Atherosclerotic disease is often diagnosed at advanced stages, with treatments typically being palliative.
• Endothelial dysfunction represents an early, subclinical change crucial for disease prevention.
• Peripheral artery assessment using noninvasive methods offers accurate insights into systemic endothelial health.

Purpose of the Study:

• To highlight the significance of detecting and treating endothelial dysfunction in the early stages of atherosclerotic disease.
• To introduce the flow-mediated dilation (FMD) method as a noninvasive tool for assessing endothelial function.
• To discuss the potential of FMD in monitoring therapeutic interventions for endothelial dysfunction.

Main Methods:

• Utilizing ultrasonography on the brachial artery to measure flow-mediated dilation (FMD).
• Employing a sphygmomanometer to induce reactive hyperemia via temporary ischemia in the forearm.
• Calculating FMD as the percentage change in brachial artery diameter post-ischemia.

Main Results:

• Flow-mediated dilation (FMD) is a reliable, noninvasive method for assessing endothelial dysfunction.
• Various treatments, including ACE inhibitors, ARBs, certain beta-blockers, statins, estrogen, diet, and exercise, have been shown to improve FMD.
• The FMD method allows for monitoring the impact of interventions on endothelial function.

Conclusions:

• Early detection of endothelial dysfunction via noninvasive methods like FMD is critical for cardiovascular disease (CVD) prevention.
• Standardization of FMD measurement techniques and values is necessary for its routine clinical adoption.
• FMD serves as a valuable biomarker for assessing vascular health and treatment efficacy.